Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.

@article{Boyer2011PredictorsOR,
  title={Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.},
  author={Thomas Boyer and Arun J Sanyal and G Garcia-Tsao and Andres Blei and Daniel Carl and Alice S. Bexon and Peter Teuber},
  journal={Journal of hepatology},
  year={2011},
  volume={55 2},
  pages={315-21}
}
BACKGROUND & AIMS Administration of terlipressin plus albumin is effective in reversing type 1 HRS as compared to albumin alone. However, only about 1/3 of patients respond to treatment, therefore, predictors of response and survival would help identify the patients most likely to benefit from treatment. METHODS We analyzed our controlled trial of terlipressin vs. placebo (Gastroenterology 2008;134:1360) to define factors predictive of a response and to correlate hemodynamic changes to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 62 extracted citations

Core Concepts in Acute Kidney Injury

Springer US • 2018
View 6 Excerpts
Highly Influenced

Pharmacological management of hepatorenal syndrome: lessons from non-responders.

Journal of hepatology • 2011
View 3 Excerpts
Highly Influenced

New Developments in Hepatorenal Syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2018

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Early indicators of outcome in type 1 hepatorenal syndrome: focus on serum creatinine in the pivotal terlipressin trial

A Keaveny, G Garcia-Tsao, A Bexon, A. Sanyal
Am J Transplant • 2009
View 1 Excerpt

Renal failure in cirrhosis.

The New England journal of medicine • 2009

Similar Papers

Loading similar papers…